Edward M. Kaye MD sold $403K of STOK stock

Edward M. Kaye MD, Dir of Stoke Therapeutics, Inc. (STOK), sold 12,567 shares of STOK stock worth $403K, per an SEC Form 4 filed Aug 19, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 14, 2026, 5 days before it was made public.

STOK has moved -15.1% since the trade date, from $31.27 to $26.54 (Nov 6, 2026 close).